Menu Back to Innovations-in-Pharmacovigilance-the-era-of-e-PV

Overview

The discipline of pharmacovigilance has undergone immense transformation throughout the world, in the last decade than ever before. With more regulatory actions being pronounced and with many countries enacting pharmacovigilance legislations, it is being increasingly recognized that patient safety is a concern for not only the regulators but other stakeholders too. Application and adoption of appropriate technology coupled with the exponential growth in the science of pharmacovigilance is revolutionizing patient safety in real time. Developing innovative workflows and deployment of relevant automation in carrying out pharmacovigilance activities indicates that the era of Electronic Pharmacovigilance has already arrived and is here to stay. Today, India holds a unique position in the pharmacovigilance space as the most preferred destination for global pharmaceutical companies to outsource their drug safety activities. In parallel, India is also firming up the country’s regulatory system to ensure utmost safety in clinical trials as well as in the post-marketing stages, which is a significant step into a promising future.

This conference aspires to bring together thought leaders representing many of the stakeholders of pharmacovigilance to deliberate the current best practices, debate on the available technology tools for data mining, elucidate on novel initiatives to augment handling of drug safety data and many other niche topics, with the focus being on pharmacovigilance and related professionals in India. The two-day conference will ensure enough opportunity to interact with speakers and colleagues from the entire spectrum of the pharmacovigilance domain in India.”

Registration Form

Learning objectives

At the end of this conference, the participants should be able to:

  • Comprehend multiple facets of global drug safety concepts along with insights on Indian pharmacovigilance
  • Understand how new technologies can help in improving adverse event reporting and processing of safety data
  • Discuss the advancements in pharmacovigilance in the European Union and how it influences the global drug safety
  • Brainstorm on special interests like pharmacovigilance of vaccines, biologics, medical devices & alternative medicines

Program Committee

  • Moin  Don
    Moin Don CEO and President
    PVCON Pharmacovigilance Consulting Services, India
  • Vivek  Ahuja
    Vivek Ahuja VP Global Pharmacovigilance
    ArisGlobal, India
  • Arun D. Bhatt, MD
    Arun D. Bhatt, MD Consultant Clinical Research & Development
    Consultant, India
  • Chitra Y. Lele, PhD
    Chitra Y. Lele, PhD Chief Scientific Officer
    Sciformix Technologies Pvt. Ltd., India
  • Himanshu  Verma
    Himanshu Verma Head Life Sciences
    Cognizant Technology Solutions India Pvt Ltd, India
  • Shravanti  Bhowmik, MD
    Shravanti Bhowmik, MD VP - Clinical Operations
    Sun Pharmaceuticals Advanced Research Co., Ltd., India
  • Sibin  Kurian
    Sibin Kurian Head, DS&E
    Novartis Healthcare Pvt. Ltd., India
  • Anish  Desai
    Anish Desai Medical Director - Medical Devices
    Johnson & Johnson Medical India, India
  • J Vijay  Venkatraman, MD, MBA
    J Vijay Venkatraman, MD, MBA Managing Director & CEO
    Oviya MedSafe Pvt Ltd, India
  • Jamal Anwar Baig, PhD
    Jamal Anwar Baig, PhD Country Head- Pharmacovigilance
    Merck Sharp & Dohme, India
  • Mangesh  Kulkarni, MD
    Mangesh Kulkarni, MD PV Offering Lead
    Tata Consultancy Services, India
  • Manoj  Swaminathan
    Manoj Swaminathan Chief Manager / Head Global Pharmacovigilance Center
    Piramal Enterprises Ltd, India
  • Milind  Sardesai
    Milind Sardesai GM - Medical Safety Services
    Cognizant Technology Solutions India, India
  • Retesh  Kumar
    Retesh Kumar Senior Business Consultant & Engagement Lead
    Tata Consultancy Services , India
Load More

Contact us

Digital Learning Catalog

eLearning Catalog Cover
Download